SCHEMBL136516

SCHEMBL136516

CN1C[CH]CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11281515 0.92
SCHEMBL98158 0.81
SCHEMBL20240530 0.81
SCHEMBL1132012 0.77
SCHEMBL935301 0.74
SCHEMBL21827323 0.74
SCHEMBL1998922 0.69
SCHEMBL27419310 0.67
SCHEMBL13330133 0.67
SCHEMBL23797204 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1936 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240226101-A1 PYRIMIDINYLAMINOBENZENES FOR LUNG CANCER TREATMENT SUZHOU PUHE BIOPHARMA CO LTD (CN) 2024-07-11 US claimed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 WO claimed
EP-4373825-A1 NITRILE SUMO INHIBITORS AND USES THEREOF Suvalent Therapeutics, Inc. (US) 2024-05-29 EP claimed
WO-2024094064-A1 PYRIMIDINYLAMINOBENZENES FOR TREATING LUNG CANCER WITH DISTANT METASTASIS SUZHOU PUHE BIOPHARMA CO., LTD (CN) 2024-05-10 WO claimed
EP-4330256-A1 PYRIMIDINYLAMINOBENZENES FOR LUNG CANCER TREATMENT Suzhou Puhe Biopharma Co., Ltd. (CN) 2024-03-06 EP claimed
CN-117561254-A Pyrimidinylaminobenzene for lung cancer treatment 苏州浦合医药科技有限公司 2024-02-13 CN claimed
US-20240002395-A1 COMPOUNDS AND THEIR USE FOR TREATING NEUROPATHIC PAIN THE JOHNS HOPKINS UNIVERSITY 2024-01-04 US claimed
US-20230416205-A1 COMPOUNDS, COMPOSITIONS, AND METHODS TENVIE THERAPEUTICS, INC. 2023-12-28 US claimed
WO-2023194964-A1 FUSED PYRIDAZINE DERIVATIVES AS NLRP3 INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2023-10-12 WO claimed
EP-4255893-A1 COMPOUNDS AND THEIR USE FOR TREATING NEUROPATHIC PAIN The Johns Hopkins University (US) 2023-10-11 EP claimed
WO-1997005877-A1 2-SUBSTITUTED ARYL PYRROLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK & CO., INC. (US) 1997-02-20 WO claimed
EP-0378111-B1 Isoxazole derivatives having anti-serotonin activity, their preparation process and compositions containing them ZAMBON SPA (IT) 1994-06-01 EP claimed
US-5250517-A Hypotensive and cardiotonic agents; cardiac insufficiency HOFFMANN-LA ROCHE INC. (US) 1993-10-05 US claimed
US-5240925-A FUNGICIDAL 2-ARYL-2-CYANO-2-(HETEROCYCLYLALKYL)ETHYL-1,2,4-TRIAZOLES ROHM AND HAAS COMPANY (US) 1993-08-31 US claimed
EP-0529973-A1 Fungicidal 2-aryl-2-cyano-2-(heterocyclylalkyl)ethyl-1,2,4-triazoles ROHM AND HAAS COMPANY (US) 1993-03-03 EP claimed
EP-0525123-A1 ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 1-BENZOPYRAN-4-ONES AND 2-AMINO-1,3-BENZOXAZINE-4-ONES. UPJOHN CO (US) 1993-02-03 EP claimed
WO-1991019707-A2 ANTIATHEROSCLEROTIC AND ANTITHROMBOTIC 1-BENZOPYRAN-4-ONES AND 2-AMINO-1,3-BENZOXAZINE-4-ONES THE UPJOHN COMPANY (US) 1991-12-26 WO claimed
US-4988691-A Analgesics, cardiovascular disorders, nervous system disorders ZAMBON GROUP S.P.A. (IT) 1991-01-29 US claimed
EP-0378111-A1 Isoxazole derivatives having anti-serotonin activity, their preparation process and compositions containing them ZAMBON GROUP S.p.A. (IT) 1990-07-18 EP claimed
EP-0079740-B1 ANTHRANILOYLOXYALKANOATES RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) 1985-11-13 EP claimed